OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 10/07/2022
Week ended 10/07/2022
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 10/07/2022
The Week’s Largest Closed Equity Transaction:
- On October 4, 2022, The Biopharmaceutical Research Company (Private)(“BRC”), one a few U.S companies with a production license from the DEA to produce cannabinoids for federally approved researchers announced the closing of a $20M Series A round.
- The round was led by Intrinsic Capital, with participation by Argonautic Ventures, AFI Capital Partners, Delta Emerald Ventures, and several family offices.
- Proceeds will allow BRC to scale its operations, increase its product offerings, conduct research and execute its go-to-market strategy.
Another Closed Equity Transaction:
- On October 4, 2022, Akerna Corporation (KERN: Nasdaq) issued 500,000 shares of convertible preferred stock for total proceeds of $4.75 million.
- The preferred was issued at a 5% discount to its $10 par value and is redeemable at the option of the holders for 105% of par for a short period ending 90 days after the offering.
- The preferred is convertible any time after the reverse stock split at $.25 per share.
Public Company Raises:
- One of the companies that raised capital this week is public and trades in the U.S. on Nasdaq.
Equity vs. Debt Cap Raises:
- Equity accounted for both of this week’s raises.
Week ended 10/07/2022
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 10/07/2022
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 10/07/2022
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.